146 related articles for article (PubMed ID: 8210633)
21. BFM program in treatment of childhood ALL--statistical evaluation of prognostic factors.
Derulska D; Rokicka-Milewska R; Lewicki Z
Acta Paediatr Jpn; 1988 Jun; 30(3):359-67. PubMed ID: 3150222
[No Abstract] [Full Text] [Related]
22. Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany.
Ritter J; Creutzig U; Reiter A; Riehm H; Schellong G
J Cancer Res Clin Oncol; 1990; 116(1):100-3. PubMed ID: 2179227
[No Abstract] [Full Text] [Related]
23. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt.
Settin A; Al Haggar M; Al Dosoky T; Al Baz R; Abdelrazik N; Fouda M; Aref S; Al-Tonbary Y
Hematology; 2007 Apr; 12(2):103-11. PubMed ID: 17454190
[TBL] [Abstract][Full Text] [Related]
24. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
[TBL] [Abstract][Full Text] [Related]
25. Results and significance of six randomized trials in four consecutive ALL-BFM studies.
Riehm H; Gadner H; Henze G; Kornhuber B; Lampert F; Niethammer D; Reiter A; Schellong G
Haematol Blood Transfus; 1990; 33():439-50. PubMed ID: 2182435
[No Abstract] [Full Text] [Related]
26. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
Takeuchi J
Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
[No Abstract] [Full Text] [Related]
27. Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987.
Zintl F; Malke H; Reimann M; Dörffel W; Domula M; Eggers G; Exadaktylos P; Kotte W; Krause I; Kunert W
Haematol Blood Transfus; 1990; 33():478-82. PubMed ID: 2182440
[No Abstract] [Full Text] [Related]
28. CD34 antigen expression in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Azuma E; Umemoto M; Kubo M; Ohta Y; Zhang SL; Komada Y; Ito M; Sakurai M
Cancer; 1991 Mar; 67(6):1565-9. PubMed ID: 1705862
[TBL] [Abstract][Full Text] [Related]
29. Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.
Jaime-Pérez JC; López-Razo ON; García-Arellano G; Pinzón-Uresti MA; Jiménez-Castillo RA; González-Llano O; Gómez-Almaguer D
Arch Med Res; 2016 Nov; 47(8):668-676. PubMed ID: 28476194
[TBL] [Abstract][Full Text] [Related]
30. AML1 amplification in a child with acute lymphoblastic leukemia.
Alvarez Y; Coll MD; Bastida P; Ortega JJ; Caballín MR
Cancer Genet Cytogenet; 2003 Jan; 140(1):58-61. PubMed ID: 12550760
[TBL] [Abstract][Full Text] [Related]
31. [Outcome of childhood high-risk acute lymphoblastic leukemia treated with the ALL-BFM 95 protocol].
Ruan YS; Wu XD; Feng XQ; He YL; Zhang YM; Pei FY; Li CF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Apr; 17(4):327-31. PubMed ID: 25919549
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
Pinheiro Junior ED; Pracchia LF; Beitler de Mauriño B; Martinez GA; Dorlhiac-Llacer PE; Medina AB; Velloso ED
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e7-e14. PubMed ID: 25130688
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the biological characteristics of infant acute leukemia].
Ma XL; Wu MY; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):128. PubMed ID: 19538890
[No Abstract] [Full Text] [Related]
34. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Li Y; Qiu L; Zou D; Zhao Y; Mi Y; Wang J
Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658
[TBL] [Abstract][Full Text] [Related]
35. Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols.
Gottardo NG; Jacoby PA; Sather HN; Reaman GH; Baker DL; Kees UR
Leukemia; 2005 Sep; 19(9):1705-8. PubMed ID: 15990867
[No Abstract] [Full Text] [Related]
36. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
Wang Y; Zeng HM; Zhang LP
Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
Attarbaschi A; Morak M; Cario G; Cazzaniga G; Ensor HM; te Kronnie T; Bradtke J; Mann G; Vendramini E; Palmi C; Schwab C; Russell LJ; Schrappe M; Conter V; Mitchell CD; Strehl S; Zimmermann M; Pötschger U; Harrison CJ; Stanulla M; Panzer-Grümayer R; Haas OA; Moorman AV;
Br J Haematol; 2012 Sep; 158(6):772-7. PubMed ID: 22816614
[TBL] [Abstract][Full Text] [Related]
38. The treatment of children with acute lymphoblastic leukemia in Thailand.
Laosombat V; Wongchanchailert M; Sattayasevana B; Wiriyasateinkul A; Watana-Arepornchai S
Med Pediatr Oncol; 2002 Apr; 38(4):266-8. PubMed ID: 11920793
[No Abstract] [Full Text] [Related]
39. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
[No Abstract] [Full Text] [Related]
40. Acute lymphoblastic leukemia presenting with hypereosinophilia: Case report and review of the literature.
Ali AM; Rashidi A; DiPersio JF
Blood Cells Mol Dis; 2017 Jun; 65():97-100. PubMed ID: 27634176
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
